vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and NOODLES & Co (NDLS). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $122.1M, roughly 1.7× NOODLES & Co). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -7.5%, a 10.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -4.1%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-2.8M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -1.2%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.

IRTC vs NDLS — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.7× larger
IRTC
$208.9M
$122.1M
NDLS
Growing faster (revenue YoY)
IRTC
IRTC
+31.3% gap
IRTC
27.1%
-4.1%
NDLS
Higher net margin
IRTC
IRTC
10.2% more per $
IRTC
2.7%
-7.5%
NDLS
More free cash flow
IRTC
IRTC
$17.3M more FCF
IRTC
$14.5M
$-2.8M
NDLS
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
-1.2%
NDLS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IRTC
IRTC
NDLS
NDLS
Revenue
$208.9M
$122.1M
Net Profit
$5.6M
$-9.2M
Gross Margin
70.9%
Operating Margin
1.1%
-5.2%
Net Margin
2.7%
-7.5%
Revenue YoY
27.1%
-4.1%
Net Profit YoY
518.5%
32.8%
EPS (diluted)
$0.18
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
NDLS
NDLS
Q4 25
$208.9M
Q3 25
$192.9M
$122.1M
Q2 25
$186.7M
$123.8M
Q1 25
$158.7M
Q4 24
$164.3M
$122.8M
Q3 24
$147.5M
$127.4M
Q2 24
$148.0M
$121.4M
Q1 24
$131.9M
$124.3M
Net Profit
IRTC
IRTC
NDLS
NDLS
Q4 25
$5.6M
Q3 25
$-5.2M
$-9.2M
Q2 25
$-14.2M
$-9.1M
Q1 25
$-30.7M
Q4 24
$-1.3M
$-6.8M
Q3 24
$-46.2M
$-13.6M
Q2 24
$-20.1M
$-6.1M
Q1 24
$-45.7M
$-6.1M
Gross Margin
IRTC
IRTC
NDLS
NDLS
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
IRTC
IRTC
NDLS
NDLS
Q4 25
1.1%
Q3 25
-4.4%
-5.2%
Q2 25
-10.0%
-5.2%
Q1 25
-20.5%
Q4 24
-2.5%
-3.9%
Q3 24
-34.1%
-9.0%
Q2 24
-15.5%
-3.4%
Q1 24
-28.9%
-3.7%
Net Margin
IRTC
IRTC
NDLS
NDLS
Q4 25
2.7%
Q3 25
-2.7%
-7.5%
Q2 25
-7.6%
-7.3%
Q1 25
-19.3%
Q4 24
-0.8%
-5.5%
Q3 24
-31.3%
-10.7%
Q2 24
-13.6%
-5.1%
Q1 24
-34.6%
-4.9%
EPS (diluted)
IRTC
IRTC
NDLS
NDLS
Q4 25
$0.18
Q3 25
$-0.16
$-0.20
Q2 25
$-0.44
$-0.20
Q1 25
$-0.97
Q4 24
$-0.03
$-0.15
Q3 24
$-1.48
$-0.30
Q2 24
$-0.65
$-0.14
Q1 24
$-1.47
$-1.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
NDLS
NDLS
Cash + ST InvestmentsLiquidity on hand
$583.8M
$4.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$-38.9M
Total Assets
$1.0B
$280.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
NDLS
NDLS
Q4 25
$583.8M
Q3 25
$565.2M
$4.7M
Q2 25
$545.5M
$1.4M
Q1 25
$520.6M
Q4 24
$535.6M
$3.3M
Q3 24
$522.0M
$1.8M
Q2 24
$561.5M
$1.3M
Q1 24
$569.1M
$3.0M
Stockholders' Equity
IRTC
IRTC
NDLS
NDLS
Q4 25
$152.7M
Q3 25
$121.9M
$-38.9M
Q2 25
$103.7M
$-13.9M
Q1 25
$86.7M
Q4 24
$90.9M
$3.7M
Q3 24
$71.8M
$9.6M
Q2 24
$99.2M
$21.9M
Q1 24
$90.3M
$27.2M
Total Assets
IRTC
IRTC
NDLS
NDLS
Q4 25
$1.0B
Q3 25
$995.2M
$280.6M
Q2 25
$964.0M
$319.4M
Q1 25
$926.1M
Q4 24
$931.4M
$340.5M
Q3 24
$909.7M
$346.3M
Q2 24
$919.2M
$360.4M
Q1 24
$909.8M
$368.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
NDLS
NDLS
Operating Cash FlowLast quarter
$26.2M
$4.3M
Free Cash FlowOCF − Capex
$14.5M
$-2.8M
FCF MarginFCF / Revenue
6.9%
-2.3%
Capex IntensityCapex / Revenue
5.6%
5.8%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$-7.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
NDLS
NDLS
Q4 25
$26.2M
Q3 25
$34.9M
$4.3M
Q2 25
$27.7M
$4.0M
Q1 25
$-7.9M
Q4 24
$19.2M
$5.8M
Q3 24
$24.3M
$4.7M
Q2 24
$11.8M
$7.0M
Q1 24
$-52.0M
$164.0K
Free Cash Flow
IRTC
IRTC
NDLS
NDLS
Q4 25
$14.5M
Q3 25
$20.1M
$-2.8M
Q2 25
$17.3M
$1.1M
Q1 25
$-17.3M
Q4 24
$12.4M
$-1.3M
Q3 24
$15.5M
$-4.5M
Q2 24
$3.4M
$-1.6M
Q1 24
$-61.8M
$-15.2M
FCF Margin
IRTC
IRTC
NDLS
NDLS
Q4 25
6.9%
Q3 25
10.4%
-2.3%
Q2 25
9.3%
0.9%
Q1 25
-10.9%
Q4 24
7.5%
-1.1%
Q3 24
10.5%
-3.5%
Q2 24
2.3%
-1.4%
Q1 24
-46.8%
-12.2%
Capex Intensity
IRTC
IRTC
NDLS
NDLS
Q4 25
5.6%
Q3 25
7.7%
5.8%
Q2 25
5.6%
2.4%
Q1 25
5.9%
Q4 24
4.2%
5.8%
Q3 24
6.0%
7.2%
Q2 24
5.7%
7.1%
Q1 24
7.4%
12.3%
Cash Conversion
IRTC
IRTC
NDLS
NDLS
Q4 25
4.70×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

NDLS
NDLS

Food And Beverage$119.6M98%
Franchise$2.5M2%

Related Comparisons